Brief: Microba Life Sciences Says Loss For The Half-Year Attributable A$5.7 Million
26/02/2025 01:19
Feb 26 (Reuters) - Microba Life Sciences Ltd MAP.AX: LOSS FOR THE HALF-YEAR ATTRIBUTABLE A$5.7 MILLION HY REVENUES FROM ORDINARY ACTIVITIES A$8.1 MILLION Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement